# BTG

BTG is a Corporate Investor based in New York, United Kingdom.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** New York, United Kingdom
- **Region:** Europe
- **Address:** Hemel Hempstead, United Kingdom
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** btgsp.com
- **LinkedIn:** https://www.linkedin.com/company/12744
- **Wikidata:** Q797061

## Regulatory record

- **CRD number:** 152538
- **SEC file number:** 801-71004
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/152538

## About

BTG is an SEC-registered investment adviser in NEW YORK, NY, registered since 2010. The firm manages $30.1 billion in assets, $29.7 billion on a discretionary basis. BTG has 180 employees and 108 investment advisers.

## Sectors

- Healthcare Services

## Questions

### What is BTG's relationship to Boston Scientific?

Boston Scientific sold BTG Specialty Pharmaceuticals to SERB Pharmaceuticals in 2021.

### Which investors back the SERB/BTG platform?

Charterhouse Capital Partners owns the platform. Partners Group and Merieux Equity Partners participate as co-investors.

## Related profiles

- [Btech Consortium](https://altss.com/profile/btech-consortium)
- [BTG Pactual Chile](https://altss.com/profile/btg-pactual-chile)

---

Source record modified: 2026-06-03T20:00:00.000Z

Last verified: not supplied by this public snapshot.

## Sources and provenance

- Organization website as recorded: https://btgsp.com/
- Regulatory source: https://adviserinfo.sec.gov/firm/summary/152538
Source links do not imply that every field was verified on the page modification date. See [Altss methodology](https://altss.com/methodology).

Canonical page: https://altss.com/profile/btg

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology